Congenital Heart Diseases
Congenital heart disease care addresses structural heart defects present from birth, using advanced imaging, catheter-based interventions, medication, and cardiac surgery tailored to each patient.

Quick answer
Congenital heart disease is a structural difference in the heart or its major blood vessels that forms before birth. Treatment depends on the specific defect and may involve regular monitoring, medication to support the heart, catheter-based procedures performed through a blood vessel, or cardiac surgery to repair the defect. Many patients need planned cardiology follow-up throughout life, even after successful repair.
Understanding Congenital Heart Disease
Congenital heart disease means that one or more parts of the heart, or the large blood vessels connected to it, formed differently before birth. It is not a single condition but a spectrum: some defects are small holes that may close on their own and only need observation, while others change the way blood moves through the heart and lungs and require medication, a catheter-based procedure, surgery, or a combination of approaches over time. Congenital heart disease affects unborn babies diagnosed during pregnancy, newborns, children, teenagers and adults — including adults who discover their condition decades after birth.
The diagnosis arrives in different ways for different families. For many, it comes during a pregnancy scan or in the first days after birth. For others, it appears later, when a child has difficulty feeding, gains weight poorly, develops a bluish skin colour, becomes breathless, faints, or when a doctor hears a heart murmur during a routine examination. Teenagers may notice that they cannot keep up with their peers in sport. Adults sometimes learn they were born with a structural heart condition only after years of mild symptoms, an abnormal heart rhythm, pregnancy planning, or an imaging test performed for an entirely different reason.
The questions that follow are practical and urgent. Will my child need open-heart surgery? Can this be treated through a catheter instead? How long does recovery take? Will further procedures be needed later? What happens as the child grows? Adults ask whether a congenital heart defect affects pregnancy, work, sport, anaesthesia for other operations, or long-term heart health. These are reasonable concerns, and the honest answer to most of them is: it depends on the specific defect, its severity, and the stage of life at which it is treated. Congenital heart disease care requires accurate diagnosis, experience with unusual anatomy, and coordination between paediatric cardiologists, adult congenital specialists, cardiac surgeons, anaesthesiologists, intensive care teams, imaging specialists and rehabilitation professionals.
At Acibadem, congenital heart disease care follows a structured, evidence-based pathway. The aim is to define the anatomy precisely, understand how the defect affects circulation, and build a personalised plan that may include monitoring, medication, interventional cardiology, cardiac surgery, or lifelong follow-up. The plan is revisited as the patient grows or circumstances change, because the right answer at six months of age is not always the right answer at sixteen.
What are the congenital heart diseases?
The congenital heart diseases are the group of structural heart defects present at birth — holes between heart chambers, narrowed or leaking valves, misplaced or underdeveloped arteries and chambers, and combinations of these. Clinicians usually group them by how they affect circulation:
- Septal defects — holes in the walls between chambers, such as atrial septal defect (ASD), ventricular septal defect (VSD) and atrioventricular septal defect.
- Valve defects — narrowed or malformed valves, such as pulmonary valve stenosis, aortic valve stenosis and Ebstein anomaly.
- Vessel defects — abnormalities of the great arteries and veins, such as patent ductus arteriosus, coarctation of the aorta and total anomalous pulmonary venous return.
- Complex and cyanotic defects — conditions that mix oxygen-rich and oxygen-poor blood or leave one pumping chamber underdeveloped, such as tetralogy of Fallot, transposition of the great arteries, truncus arteriosus, double outlet right ventricle and hypoplastic left heart syndrome.
CHD is the standard abbreviation, so when you see resources referring to CHD diseases or to congenital cardiovascular conditions, they mean this same group. The label matters less than the physiology: two children with the same named defect can need very different treatment depending on size, location and pressure effects.
What causes congenital heart disease in infants?
In most infants, no single cause is ever identified. The heart forms in the first weeks of pregnancy, often before a woman knows she is pregnant, and small variations in that process can produce a defect without any identifiable trigger. Known contributors include genetic changes and chromosomal conditions such as Down syndrome, certain maternal illnesses such as poorly controlled diabetes, some infections during pregnancy such as rubella, and exposure to certain medicines or substances during early pregnancy. In many families, several small factors probably combine — which is why one child can be born with a heart defect when siblings are not, and why parents should not assume the condition resulted from something they did or failed to do.
Is congenital heart disease genetic?
Congenital heart disease is genetic in some patients but not in most. Certain defects run in families, and some occur as part of recognised genetic syndromes that affect several organ systems. A family history of congenital heart disease modestly raises the likelihood that a child will be affected, which is one reason fetal echocardiography may be offered during pregnancy when a parent or sibling was born with a heart defect. For the majority of patients, however, the condition appears without any known family pattern, and genetic testing is used selectively — usually when a syndrome is suspected, when several family members are affected, or when the findings would change surveillance for future pregnancies.
Is a PFO a congenital heart disease?
A patent foramen ovale (PFO) is a remnant of normal fetal circulation rather than a classic congenital heart defect. Before birth, every baby has a flap-like opening between the upper heart chambers that allows blood to bypass the lungs. In most people it seals in infancy; in a substantial part of the population it remains partly open, usually without causing any symptoms at all. A PFO differs from an atrial septal defect, which is a true deficiency of tissue in the wall between the chambers. Most PFOs need no treatment. Evaluation is considered in selected situations — for example, after certain types of stroke — and the decision about closure is individual, made by a cardiologist and neurologist together.
What Is Critical Congenital Heart Disease?
Critical congenital heart disease describes the defects that need surgery or a catheter procedure within the first year of life, often within days or weeks of birth. In many of these conditions, the newborn’s circulation depends on temporary fetal pathways — such as the ductus arteriosus — that close naturally in the first days of life. When they close, a baby whose circulation relied on them can deteriorate quickly. This is why many countries screen newborns with pulse oximetry, a simple measurement of oxygen saturation on the skin, before discharge from the maternity unit: low oxygen levels can reveal a critical defect before symptoms appear.
What are the 7 critical congenital heart defects?
Newborn screening programmes commonly focus on seven conditions: hypoplastic left heart syndrome, pulmonary atresia, tetralogy of Fallot, total anomalous pulmonary venous return, transposition of the great arteries, tricuspid atresia and truncus arteriosus. These seven are highlighted because they frequently lower oxygen saturation in the first days of life, which makes them detectable by pulse oximetry. Screening can also flag other serious defects, such as coarctation of the aorta or severe valve obstruction, and a normal screening result does not rule out every heart condition — some defects only declare themselves as the child grows.
What Congenital Heart Disease Treatment Involves
Congenital heart disease treatment is the medical, catheter-based and surgical care used to manage structural heart defects present from birth. These defects can involve the walls between chambers, the heart valves, the major arteries or veins, or the overall route blood takes through the heart and lungs. Treatment is never one standard procedure. It is a tailored plan built around the specific defect, the patient’s age, symptoms, oxygen levels, heart function, lung pressures and any procedures already performed.
Some defects are simple, such as a small atrial septal defect or ventricular septal defect. Others are complex, such as tetralogy of Fallot, transposition of the great arteries, single-ventricle physiology, hypoplastic left heart syndrome or truncus arteriosus. A patient may need one treatment in infancy, staged treatments over several years, or surveillance into adulthood without any intervention at all. Modern care generally uses four approaches, alone or in sequence:
- Observation — regular cardiology follow-up when a defect is small, stable and not straining the heart or lungs. Some holes close on their own; some mild valve narrowing stays stable for years.
- Medication — to support heart function, control fluid balance, manage rhythm problems, reduce pressure in the lung circulation, or manage heart failure symptoms while a procedure is planned.
- Catheter-based intervention — treatment of selected defects through thin tubes inserted into blood vessels, often avoiding open surgery entirely.
- Cardiac surgery — repair or reconstruction of the heart: closing holes, widening narrowed pathways, repairing or replacing valves, redirecting blood flow, or creating staged circulation for complex anatomy.
Timing matters as much as technique. Some newborns need care within hours or days. Some infants do better with planned surgery after a period of growth and stabilisation. Some children need catheter procedures later as the heart develops. Adults with congenital heart disease may need evaluation for valve dysfunction, residual holes, arrhythmias, pulmonary hypertension, heart failure, or late effects of childhood repairs.
Who May Need Congenital Heart Disease Care
Congenital heart disease care may be needed by unborn babies identified during fetal screening, newborns with abnormal oxygen levels, children with murmurs or growth concerns, adolescents with exercise limitations, and adults with known or previously undiagnosed defects. The signs can be obvious or subtle — and in some patients there are no symptoms at all until a routine examination raises the question.
Symptoms in babies and children
In babies and children, typical signs include fast breathing, poor feeding, tiring or sweating during feeds, poor weight gain, frequent respiratory infections, bluish lips or fingertips, swelling, fainting, or noticeably lower activity than other children of the same age. Some babies appear entirely well and the only clue is a murmur heard at a check-up. A murmur alone does not mean a serious defect — many childhood murmurs are innocent — but it is a reason for a cardiology assessment, because examination alone cannot distinguish a harmless sound from a structural problem.
Symptoms in teenagers and adults
Older children and teenagers may describe chest discomfort, palpitations, dizziness, breathlessness with exertion, or an inability to keep up in sport. Adults may notice an irregular heartbeat, unexplained fatigue, breathlessness, swelling in the legs, fainting, declining exercise tolerance, or problems during pregnancy. Adults who had heart surgery in childhood should remain under specialist review even if they feel completely well, because repaired congenital heart disease can change over time — valves can begin to leak or narrow, chambers can enlarge, and rhythm disturbances can develop years after a technically successful operation.
How the diagnosis is made
Diagnosis begins with a detailed history and physical examination, followed by cardiac testing. Echocardiography is usually the central investigation: it uses ultrasound to show the chambers, the valves, blood flow and most structural defects without radiation. Fetal echocardiography can identify significant heart disease before birth, which allows delivery planning and immediate newborn care where needed. Electrocardiography shows rhythm disturbances or chamber strain. A chest X-ray gives information about heart size and lung blood flow. Cardiac MRI and cardiac CT define complex anatomy, vessels, previous repairs and heart function in greater detail, particularly in older children and adults. In selected cases, cardiac catheterisation measures pressures and oxygen levels directly inside the heart and can move seamlessly from diagnosis to treatment in the same session. Evaluation is also sensible for anyone with a known congenital diagnosis, abnormal oxygen saturation, a family history of congenital heart disease, a genetic syndrome associated with heart defects, recurrent unexplained respiratory symptoms, or abnormal prenatal ultrasound findings.
Conditions and Indications Addressed
Congenital heart disease sits within the broader field of congenital disease, and cardiac care covers a wide range of structural and functional problems. Some defects push extra blood towards the lungs. Others restrict blood reaching the lungs, mix oxygen-rich and oxygen-poor blood, obstruct blood leaving the heart, or damage valves over time. The treatment team weighs not just the name of the condition but its severity, anatomy, pressure effects, oxygenation, rhythm status, and impact on growth or daily function.
Commonly treated conditions include atrial septal defect, ventricular septal defect, patent ductus arteriosus, atrioventricular septal defect, pulmonary valve stenosis, aortic valve stenosis, coarctation of the aorta, tetralogy of Fallot, transposition of the great arteries, total anomalous pulmonary venous return, truncus arteriosus, double outlet right ventricle, Ebstein anomaly, single-ventricle conditions, and hypoplastic left heart syndrome. Coarctation and other abnormalities of the aorta are closely related to the wider field of aortic diseases, and congenital valve problems overlap with acquired heart valve diseases in how they are assessed and repaired. Care is also needed for complications after previous repair: valve leakage or narrowing, residual holes, narrowed arteries, abnormal rhythms, or declining heart function.
Indications for treatment can include low oxygen levels, heart failure symptoms, poor growth, excessive blood flow to the lungs, elevated lung pressures, narrowing that strains the heart muscle, valve disease, enlargement of heart chambers, recurrent infection of the heart’s inner lining, stroke risk related to certain shunts, or rhythm disturbances. Treatment may also be recommended before pregnancy, before major non-cardiac surgery, or before a child takes up more intensive physical activity if the defect creates measurable risk in those settings.
Not every congenital defect needs intervention, and not every defect that needs intervention needs it now. Some small holes close on their own. Mild valve narrowing may stay stable for years. Certain repaired conditions need surveillance rather than active treatment. This is where expert interpretation earns its place: overtreatment exposes a patient to unnecessary procedural risk, while undertreatment can allow avoidable damage to the heart, lungs or circulation to accumulate quietly.
How Congenital Heart Disease Treatment Is Performed
Preparation and Diagnostic Planning
Care begins with a precise diagnosis. The process often starts with a structured review of existing medical records, imaging reports, previous operation notes, echocardiograms, catheterisation reports and laboratory results. If the patient is a fetus or newborn, planning focuses on delivery, early oxygen and circulation needs, and whether treatment may be required immediately after birth. For children and adults, the team reviews symptoms, growth pattern, exercise capacity, current medications, previous procedures and family history.
From there, the diagnostic pathway may include echocardiography, electrocardiography, blood tests, oxygen saturation assessment, cardiac MRI, cardiac CT, exercise testing, rhythm monitoring or cardiac catheterisation. These tests answer the questions that drive every decision: where does blood actually flow, which chambers are enlarged, how do the valves function, are pressures elevated, and is the heart muscle under strain. In complex cases, the findings are discussed in multidisciplinary cardiac boards, where cardiologists, surgeons and imaging specialists decide together whether observation, medication, catheter intervention, surgery or staged treatment fits best.
Before a procedure, you receive clear instructions about fasting, anaesthesia, infection prevention and the expected hospital stay; questions about your current medicines are answered by the treating doctor, who decides how they should be handled around the procedure. Children are prepared in an age-appropriate way to reduce fear. Adults receive counselling about work, travel, activity and — where relevant — pregnancy considerations. If surgery is planned, blood typing, anaesthesia evaluation, imaging review and intensive care planning are completed in advance.
Medication and Monitoring
Medication can be a primary treatment for some patients or a bridge to a procedure for others. Newborns with certain critical defects receive medicines that keep fetal circulation pathways temporarily open until surgery or catheter treatment can be performed. Infants with heart failure symptoms may receive medicines that remove excess fluid, support heart function, or improve feeding and growth. Patients with rhythm problems may need antiarrhythmic medication, anticoagulation in selected situations, or an electrophysiology evaluation.
Monitoring itself is an active form of care, not the absence of care. Follow-up visits typically include echocardiography, rhythm assessment, growth evaluation, oxygen saturation measurement and a structured review of symptoms. The timing of any future intervention is adjusted as the patient grows, symptoms change, or imaging shows increasing strain on the heart. When the heart muscle itself weakens or thickens as a consequence of a long-standing defect, assessment overlaps with the evaluation of myocardial diseases.
Catheter-Based Interventions
Many congenital defects can be treated in a cardiac catheterisation laboratory without opening the chest. Thin, flexible tubes are inserted through a blood vessel — usually in the groin — and guided to the heart under real-time imaging. Depending on age, condition and complexity, the patient receives general anaesthesia or deep sedation.
Catheter techniques can close selected atrial septal defects and patent ductus arteriosus, widen narrowed valves or vessels with balloons, place devices that keep vessel openings patent, measure pressures directly, or map complex anatomy before surgery. For suitable patients, the advantages are real: no chest incision, a shorter hospital stay, and a quicker return to normal activity than after major surgery. The limits are equally real: not every defect is suitable for catheter repair. Size, location, the quality of surrounding tissue, valve involvement and pressure measurements all determine whether this route is safe and effective — and a defect that looks closable on paper is sometimes found unsuitable once measured directly.
Cardiac Surgery
Cardiac surgery is recommended when a defect requires direct repair, reconstruction, redirection of blood flow or staged correction. Depending on the condition, the operation may close holes between chambers, repair or replace valves, relieve obstructions, reconstruct the aorta or pulmonary arteries, switch the positions of major arteries, connect veins correctly, or build circulation pathways for single-ventricle anatomy. Some operations are corrective. Others are deliberately palliative or staged — they improve circulation now and prepare the patient for a further procedure later, which is the standard approach for several complex conditions.
Many congenital heart operations use cardiopulmonary bypass, in which a heart-lung machine temporarily supports circulation while the surgeon works on a still heart. Some procedures can be done without bypass, depending on the anatomy. Paediatric and congenital cardiac anaesthesia is a specialty in its own right, particularly for newborns and patients with fragile physiology. After surgery, patients recover in a cardiac intensive care unit with continuous monitoring of rhythm, oxygenation, blood pressure, ventilation, fluid balance and organ function.
Durations vary widely. A diagnostic catheterisation may take a few hours including preparation and recovery. Some catheter interventions need one night in hospital; complex ones need longer observation. Surgical stays range from several days for straightforward repairs to considerably longer for newborns, complex anatomy, staged surgery, or patients who need additional support after the operation. In adults, the surgical plan sometimes also addresses acquired problems found at the same time, such as coronary artery diseases.
Technology Used in Congenital Heart Disease Care
Technology supports decision-making and safety at every step. High-resolution echocardiography shows anatomy and blood flow without radiation. Fetal echocardiography brings the diagnosis forward to before birth. Cardiac MRI measures heart volumes, function, flow patterns and the major vessels in detail, which matters most in older children and adults with repaired defects. Cardiac CT defines complex vascular anatomy rapidly, which can be decisive for surgical planning. Three-dimensional image processing helps teams understand the spatial relationships between chambers, valves and vessels in hearts that do not follow the textbook.
In the catheterisation laboratory, live X-ray imaging, ultrasound guidance, pressure measurement systems and contrast imaging allow specialists to navigate and treat safely. In surgery and intensive care, continuous monitoring, transoesophageal echocardiography where appropriate, ventilatory support, blood gas analysis and circulatory support systems are used according to the patient’s needs. The purpose of all of it is not sophistication for its own sake — it is to reduce uncertainty, refine timing, and match the treatment to the individual anatomy and physiology in front of the team.
Recovery Process
Recovery depends on the diagnosis, the patient’s age, the treatment performed and overall health. After catheter treatment, monitoring focuses on the access site, heart rhythm, oxygen levels and — when a closure device was implanted — device position. Children usually return to quiet activities relatively quickly; strenuous activity is restricted for a period the cardiologist defines individually.
After surgery, recovery begins in the cardiac intensive care unit. Some patients need breathing support for a short time. Pain control, fluid management, nutrition, wound care and early mobilisation are the pillars of the first days. Babies may need feeding support while they regain strength; older children and adults gradually increase walking and daily activity. Follow-up imaging confirms how the repair is functioning and guides any medication adjustments, which the treating team makes and explains.
Return to school, nursery or work is planned individually. Many children go back to the classroom within weeks of surgery, initially excused from sport and heavy lifting while the breastbone heals; catheter patients often resume routines sooner. The cardiology team defines when full activity is appropriate based on the defect, the procedure performed and follow-up imaging, and adjusts the plan at each visit rather than applying a fixed rule to every patient.
Why Acting Early Matters
Early evaluation matters because congenital heart disease can affect the heart, lungs, brain, growth and physical development over time. Some defects add workload to the heart muscle. Others send too much blood to the lungs, which can gradually raise lung pressures and make later repair harder or, eventually, impossible. Cyanotic defects lower oxygen levels, affecting energy, feeding, growth and organ function. Narrowed valves or vessels can cause the heart muscle to thicken or weaken if left unaddressed.
In newborns with critical congenital heart disease, delay is genuinely dangerous, because circulation may depend on temporary fetal pathways that close naturally in the first days of life. Prompt diagnosis allows medication, intensive monitoring, catheter treatment or surgery to be arranged before severe instability develops. For infants and children, timely treatment supports growth, reduces symptoms and prevents progressive strain. For adults, early specialist review can pick up rhythm problems, valve disease, residual defects, pulmonary hypertension or heart failure while they are still simpler to manage.
Delay does not always mean harm, and some conditions are safely watched for years. The point is not to rush — it is not to wait without an informed plan. A structured evaluation establishes whether the safest course is treatment now, close follow-up, or a planned intervention at a defined later stage, and it puts a date and a reason on that decision rather than leaving it open.
Benefits of Congenital Heart Disease Treatment
The potential benefits depend on the condition and the treatment chosen, but the goals are consistent: improve circulation, protect heart and lung function, and support long-term quality of life.
| Benefit | What It Means for You |
|---|---|
| Improved blood flow and oxygen delivery | Treatment can help blood move through the heart and lungs more effectively, reducing cyanosis, breathlessness, fatigue or feeding difficulty in suitable patients. |
| Protection of heart and lung function | Repairing or managing defects at the right time may reduce long-term strain on the heart muscle and help prevent avoidable pressure changes in the lung circulation. |
| Better growth and activity tolerance | Children may feed better, gain weight more appropriately, and take part more comfortably in age-appropriate activity when circulation improves. |
| Lower risk of selected complications | Depending on the diagnosis, treatment may reduce risks related to heart failure, rhythm problems, recurrent infections, blood clots, or worsening valve and vessel disease. |
| A clear long-term care plan | Specialist follow-up clarifies activity, medications, future procedures, pregnancy planning, dental precautions and the transition into adult congenital heart care. |
Recovery Timeline After Congenital Heart Disease Treatment
Recovery varies widely between patients, but the following gives a general picture of what many families can expect after catheter-based or surgical treatment.
| Time Period | What Patients Can Expect |
|---|---|
| Day 1 | After catheter treatment, monitoring focuses on access-site healing, heart rhythm, oxygen levels and comfort. After surgery, patients are usually in cardiac intensive care with close monitoring and support as needed. |
| First week | Catheter patients may return to gentle daily activities if stable. Surgical patients gradually come off intensive support, begin feeding or walking as appropriate, and receive wound care, pain control and follow-up imaging. |
| First month | Activity increases gradually. Follow-up visits assess healing, heart function, medications, rhythm and any remaining restrictions. Babies may need nutrition support and growth monitoring. |
| Longer term | Many patients need periodic cardiology follow-up even after successful repair. The schedule depends on the defect, the treatment performed, valve function, rhythm status, and growth or life-stage changes. |
Long-Term Outlook: Living With a Congenital Heart Defect
The long-term outlook in congenital heart disease has changed profoundly over the past decades, and the questions families ask about it deserve straight answers rather than reassurance without content.
Can you live a normal life with a congenital heart defect?
Many people with a congenital heart defect live full, active lives — attending school, working, exercising, travelling and having families of their own. How close to “normal” life looks depends on the specific defect and its treatment. Someone with a small repaired septal defect may face few restrictions beyond periodic check-ups. Someone with single-ventricle circulation lives with real limits and a structured medical relationship for life. Between those two ends of the spectrum sit most patients, whose activity, sport participation and pregnancy plans are shaped individually with their cardiologist rather than by blanket rules.
What is the life expectancy of someone with congenital heart disease?
There is no single life expectancy figure for congenital heart disease, because the term covers everything from a small hole that closes on its own to complex single-ventricle anatomy. What can honestly be said is that modern diagnosis, surgery, catheter techniques and intensive care have transformed the outlook compared with earlier generations, and that adults living with congenital heart disease are now a large and growing patient population — which is precisely why adult congenital heart disease has become a specialty of its own. For an individual, the meaningful answer comes from their own cardiologist, who knows the defect, the repair and the follow-up findings.
Can congenital heart disease be cured?
Repair is a more accurate word than cure. Many defects can be repaired so effectively that the patient grows, exercises and lives without day-to-day limitation. But a repaired heart is not identical to a heart that formed typically: patches, reconstructed valves and redirected circulation can change over decades, and some conditions are managed in stages rather than fixed once. That is why lifelong specialist follow-up is recommended for most patients with anything beyond the simplest defects — not because trouble is expected, but because changes are easiest to manage when found early.
Factors That Influence Outcomes and a Good Result
Outcomes in congenital heart disease depend on many factors: the specific diagnosis, the complexity of the anatomy, age at treatment, oxygen levels, lung pressures, heart function, associated genetic or medical conditions, and whether the patient has had previous procedures. A small isolated defect repaired at the right time is a very different situation from a complex single-ventricle condition requiring staged surgery and lifelong specialist care, and it is unhelpful to talk about them as if they carried the same journey.
Accurate diagnosis is one of the most important factors of all. Congenital heart anatomy is highly individual, and decisions often hinge on details: valve size, vessel position, chamber development, direct pressure measurements, and the relationships between multiple defects in the same heart. High-quality imaging and careful interpretation reduce uncertainty and support the right choice between catheter treatment, surgery and observation.
Timing matters just as much. Some interventions are safest in the newborn period. Others are deliberately planned after the child grows. Some adults benefit from intervention before irreversible heart or lung changes develop. A good result usually reflects a balanced judgement — the risks of intervening too early weighed honestly against the risks of intervening too late.
The experience of the care team carries particular weight in complex conditions, reoperations, neonatal heart surgery, adult congenital heart disease and patients with multiple medical issues. Multidisciplinary review lets cardiologists, surgeons, anaesthesiologists, intensivists and imaging specialists consider the patient from several angles at once, which matters because a congenital heart condition is never only an anatomic problem: it touches circulation, growth, breathing, rhythm, development and long-term life planning.
Finally, recovery and long-term results are shaped by what happens after discharge: postoperative care, infection prevention, nutrition, rehabilitation, medication adherence and follow-up attendance. Families are central to this, especially with infants and children — they leave hospital with clear instructions on feeding, wound care, fever, breathing changes, medication schedules and activity limits. Adults need guidance on exercise, pregnancy, anticoagulation where prescribed, and dental care and oral health, which matters in congenital heart disease because of the link between oral bacteria and infection of the heart’s inner lining.
Congenital Heart Disease Care at Acibadem
Families weighing up congenital heart care usually need more than an appointment. They need confidence that the diagnosis will be reviewed carefully, that the treatment plan will be explained in plain terms, and that the hospital can coordinate complex care across several clinical specialties at once. Congenital heart disease care can involve urgent decisions, staged treatment, intensive care and long follow-up, so organisation and communication are part of the medicine, not an extra.
At Acibadem, patients are evaluated by physicians in paediatric cardiology, adult congenital cardiology, cardiovascular surgery, cardiac anaesthesia, intensive care, radiology and related specialties, working to internationally accepted diagnostic and treatment protocols. Complex cases are discussed in multidisciplinary boards, where imaging findings, surgical options, catheter-based alternatives, timing and postoperative needs are reviewed together before anything is recommended.
For babies and children, the pathway is built around medical safety and family support at the same time. Parents receive explanations of the diagnosis, the options, the expected hospital stay, the recovery and the follow-up plan. For newborns with critical heart disease, coordination between obstetrics, neonatology, paediatric cardiology, cardiac surgery and intensive care can be essential from before delivery. For older children and teenagers, the team considers growth, school, activity, emotional readiness and the eventual transition into adult congenital care.
For adults, the approach recognises that congenital conditions do not end with childhood repair. Adults may need assessment for valve disease, arrhythmias, heart failure, pulmonary hypertension, pregnancy risk or revision procedures, and specialist evaluation clarifies whether current symptoms relate to the congenital condition and whether treatment, monitoring or lifestyle adjustment fits best. Diagnosis and treatment are supported by modern echocardiography, cardiac MRI and CT, catheterisation laboratories, intensive care monitoring and surgical planning tools — used to answer specific clinical questions rather than for their own sake. Care coordination also covers the practical side — appointment scheduling, medical record transfer, and admission and discharge planning — so that families can concentrate on medical decisions and recovery rather than logistics.
Not every patient assessed will be advised to have a procedure. Some proceed to catheter treatment or surgery; some are monitored; some need further diagnostic clarification before any decision is sound. The aim throughout is to align treatment with the individual patient’s anatomy, physiology, age, symptoms and long-term plans.
Planning the Path Forward
A congenital heart diagnosis can feel overwhelming — especially when decisions concern a baby or child, or when an adult diagnosis raises sudden questions about the future. The path through it is the same in every case: an accurate picture of the anatomy, an honest account of what it means for circulation now and later, and a plan with a clear rationale for its timing.
Many families also seek a second specialist opinion before a proposed procedure, and in congenital cardiology that is a normal and sensible part of the process rather than a sign of distrust. A structured review of records, imaging and previous operation notes usually clarifies whether observation, medication, catheter-based intervention, surgery or ongoing specialist follow-up best fits the patient at this stage of life — and, just as importantly, why.
Preparation
- Preparation begins with a detailed cardiology assessment, echocardiography, ECG, blood tests, and other imaging when needed. The medical team reviews medications, feeding or activity concerns in children, and any infection risks. Patients may need to fast before surgery or catheter-based treatment and follow specific instructions on blood thinners or regular medicines.
Aftercare
- After treatment, patients are monitored in intensive care or a cardiac unit until heart rhythm, breathing, and circulation are stable. Follow-up includes wound care, medication management, echocardiography, and guidance on activity, nutrition, and infection prevention. Long-term cardiology follow-up is often needed, especially for children as they grow.
Turkey vs UK, Germany & USA
Congenital heart disease care can range from ongoing monitoring to catheter-based procedures or complex cardiac surgery. Costs and patient experience vary by diagnosis, age, hospital resources, specialist team, and the level of follow-up required.
The comparison below focuses on practical factors that may influence overall cost and planning for international patients seeking congenital heart disease evaluation or treatment.
| Factor | Turkey | UK | Germany | USA |
|---|---|---|---|---|
| Price drivers | Diagnosis complexity, imaging, catheter lab use, intensive care needs, surgery type, implant or device selection, and length of stay. | Private care costs are influenced by consultant fees, hospital charges, imaging, operating theatre use, and post-procedure care. | Costs depend on university or private hospital setting, specialist fees, diagnostics, device choice, and inpatient pathway. | Costs are strongly affected by hospital billing structure, insurance status, surgeon and facility fees, devices, intensive care, and follow-up. |
| Hospital and surgeon factors | International hospitals may offer pediatric and adult congenital cardiology, cardiac surgery, catheter interventions, and coordinated case management in one program. | Specialist congenital heart centers are available, with pathways often shaped by public or private access routes. | Large cardiac centers may provide advanced imaging, interventional cardiology, and surgical expertise for complex defects. | Major children’s and academic hospitals often provide highly specialized congenital heart teams, with billing varying widely by provider network. |
| Accreditation and quality | Patients may look for JCI-accredited hospitals, multidisciplinary heart boards, pediatric intensive care capability, infection control standards, and international patient services. | Quality is assessed through national regulation, hospital governance, specialist center designation, and consultant credentials. | Quality indicators include certified cardiac programs, specialist training, hospital outcomes governance, and structured clinical protocols. | Quality is assessed through hospital accreditation, specialist center experience, surgeon credentials, and institutional outcome reporting. |
| Typical waiting and scheduling | Private international pathways may support coordinated appointments, imaging, and treatment planning after medical record review. | Public pathways may involve waiting, while private appointments can depend on consultant and theatre availability. | Scheduling depends on referral review, center capacity, and whether the case is elective or urgent. | Scheduling may be rapid in private or insured networks, but authorization, referrals, and provider availability can affect timing. |
| Travel and language logistics | International patient departments commonly assist with translation, airport transfer guidance, accommodation coordination, and communication with families. | English is standard, but international patients may need support with records, referrals, and private payment arrangements. | Translation support may be needed; international offices can assist with appointments, documents, and stay planning. | English is standard, while international patients may need help navigating insurance, billing, visas, and medical record transfer. |
| What a package may include | Packages may include specialist consultation, diagnostic planning, hospital stay, procedure or surgery, standard medications during admission, translation support, and discharge coordination. | Private packages may include consultation, selected tests, hospital fees, and procedure-related care, with exclusions varying by provider. | Packages may cover consultation, diagnostics, inpatient care, procedure fees, and discharge documentation, depending on the hospital offer. | Bundled estimates may be available, but separate charges for facility, physician, anesthesia, devices, and aftercare are common. |
What affects your final cost:
- The exact heart defect and whether more than one defect is present.
- The patient’s age, weight, symptoms, and overall medical condition.
- The need for echocardiography, cardiac MRI, CT angiography, catheterization, genetic testing, or other diagnostics.
- Whether treatment involves medication, catheter-based intervention, open heart surgery, hybrid treatment, or staged care.
- Use of intensive care, blood products, implants, patches, valves, stents, closure devices, or other materials.
- Length of hospital stay, recovery needs, and follow-up schedule.
- Travel, accommodation, translation, companion arrangements, and post-discharge coordination.
Compare your options
Congenital heart disease treatment is individualized according to anatomy, symptoms, age, growth, oxygen levels, heart function, and previous procedures. Suitability for any option is decided by a congenital cardiology and cardiac surgery specialist team.
| Option | What it is | Typical use | Key considerations |
|---|---|---|---|
| Monitoring and medical management | Regular specialist follow-up with echocardiography, rhythm assessment, medication, nutrition support, and activity guidance. | Mild defects, stable patients, preparation before an intervention, or long-term adult congenital heart disease follow-up. | Cost depends on frequency of visits, imaging, medications, and whether symptoms change over time. |
| Advanced diagnostic assessment | Detailed evaluation using echocardiography, cardiac MRI, CT angiography, catheterization, rhythm monitoring, and laboratory testing when needed. | Confirming anatomy, planning surgery or catheter treatment, assessing pressure, blood flow, valves, vessels, and heart function. | Diagnostic depth is a major cost driver and helps the team choose the safest and most appropriate pathway. |
| Catheter-based intervention | A minimally invasive procedure performed through blood vessels to close selected holes, widen narrowed areas, place stents, or treat certain valve or vessel problems. | Selected atrial septal defects, patent ductus arteriosus, some valve or vessel narrowings, and other suitable lesions. | Not all defects are suitable; device type, catheter lab time, anesthesia, imaging, and overnight monitoring can affect cost. |
| Cardiac surgery | Open or minimally invasive surgical repair or palliation performed by a congenital cardiac surgery team, often with intensive care afterward. | Complex structural defects, defects not suitable for catheter treatment, valve repair, vessel reconstruction, or staged repair pathways. | Cost is influenced by surgical complexity, operating time, intensive care, blood management, implants, recovery, and possible staged planning. |
| Hybrid treatment | A coordinated approach combining catheter-based and surgical techniques in the same treatment strategy. | Selected complex cases where combining methods may reduce risk or improve repair planning. | Requires a highly coordinated team; costs reflect the combined use of operating room, catheter lab, imaging, and specialized staff. |
| Long-term adult congenital care | Specialist follow-up for people born with heart defects who are now adults, including surveillance, pregnancy counseling, rhythm care, and reintervention planning. | Adults with repaired or unrepaired congenital heart disease, valve problems, rhythm issues, or late complications. | Ongoing cost depends on monitoring needs, imaging, medications, lifestyle counseling, and whether future procedures are required. |
General information only — not medical or financial advice. Final costs depend on the factors above and your individual case; request a free, personalised quote.
Frequently Asked Questions
What affects the cost of congenital heart disease treatment?
The main factors are the exact diagnosis, disease complexity, age and condition of the patient, required imaging, whether catheter treatment or surgery is needed, intensive care requirements, devices or implants, hospital stay, and follow-up needs.
How can I get a personalised quote from Acibadem?
You can request a free consultation by sharing medical reports, echocardiography results, imaging files, catheterization reports if available, medication lists, and previous surgery notes. The congenital heart team reviews the case and prepares a personalised treatment and cost estimate.
Is the quoted cost the same for every congenital heart defect?
No. Congenital heart diseases vary widely, from defects that only need observation to complex conditions requiring staged procedures. A specialist assessment is necessary before a reliable estimate can be provided.
What is usually included in an international patient package?
Depending on the treatment plan, a package may include specialist consultation, selected diagnostics, hospital stay, procedure or surgery, standard inpatient medications, translation support, discharge documents, and coordination with the international patient team. Inclusions and exclusions should always be confirmed in writing.
Can travel and accommodation change the total budget?
Yes. Flights, accommodation, companion stay, local transport, translation needs, and the duration of recovery in Turkey can affect the total budget beyond medical charges.
Is this information medical or financial advice?
No. This is general educational information. Treatment suitability and final cost should be confirmed after a specialist review and a personalised consultation.
Medically reviewed by the Acıbadem International Medical Board — August 30, 2026
See our medical review board →
Update history
- PublishedJune 5, 2026
- Medical review approvedAugust 30, 2026
- Last content updateAugust 30, 2026
References2
- Congenital Heart Defects — medlineplus.gov
- Congenital heart disease — nhs.uk
Trusted care for international patients
Doctors Performing This Treatment

Prof. Dr. Cahide Soydaş Çınar
Cardiology
Prof. Dr. Metin Gürsürer
Cardiology
Prof. Dr. Elif Eroğlu Büyüköner
Cardiology
Prof. Dr. Ahmet Akyol
Cardiology
Prof. Dr. Ahmet Karabulut
Cardiology
Prof. Dr. Mustafa Hakan Dinçkal
Cardiology
Prof. Dr. Sinan Dağdelen
Cardiology
Prof. Dr. Ahmet Kaya Bilge
Cardiology
Prof. Dr. Duhan Fatih Bayrak
Cardiology
Prof. Dr. Barış Kılıçaslan
Cardiology
Prof. Dr. Aleks Değirmencioğlu
Cardiology
Prof. Dr. Alper Özkan
Cardiology
Prof. Dr. Gültekin Karakuş
Cardiology
Prof. Dr. Refik Erdim
Cardiology
Prof. Dr. Mert İlker Hayıroğlu
Cardiology
Prof. Dr. Osman Bilgin Timuralp
Cardiology
Prof. Dr. Ethem Kumbay
Cardiology
Prof. Dr. Ali Aydınlar
Cardiology
Prof. Dr. Ender Semiz
Cardiology
Prof. Dr. Ercüment Yılmaz
Cardiology
Prof. Dr. Bekir Sıtkı Cebeci
Cardiology
Prof. Dr. Haldun Akgöz
Cardiology
Prof. Dr. Ergün Seyfeli
Cardiology
Prof. Dr. Mustafa Kemal Batur
CardiologyMedical Units
Available at These Hospitals












